Please assess the completion status of the following clinical trial:

Trial Title: CoSeal in Liver and Biliary Surgery in Prevention of Denovo Hepatic Adhesion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Major patients.~* Hepatic Carriers of metastases.~* Eligible with a procedure of surgical eradication in two brought closer times (time lower than 3 months).~* Strategy validated in multidisciplinary meeting of cancerology.~* Enlightened Assent given and signed before the intervention.~Exclusion Criteria:~* Anaesthetic Counter-indications with a procedure in two times~* Carcinose péritonéale, reached metastatic not éradicable~* Over-sensitiveness or allergy known to polyethylene CoSeal glycol~* Concomitant Use of another antiblocking agent~* Immunodéprimés Patients or taking drugs immunodépresseurs with the long court like the corticosteroids,~* Impossibility of subjecting itself to the medical monitoring imposed by the study for reasons geographical, social, psychic or medical.~* Concomitant Participation in another clinical trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Group COSEAL (Type: EXPERIMENTAL): None
- Reference group (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).